Next Issue
Volume 24, 09
Previous Issue
Volume 24, 05
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 24, Issue 4 (07 2021) – 12 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
4 pages, 1415 KB  
Editorial
Artificial Intelligence: The Stairway to Better Medicine?
by Thomas F. Lüscher
Cardiovasc. Med. 2021, 24(4), w10075; https://doi.org/10.4414/cvm.2022.02170 - 1 Jul 2022
Abstract
Artificial intelligence in science
Artificial intelligence (AI) is centre stage in many scientific fields. PubMed lists an impressive number of publications on the topic; as of end of May, 397,379 articles just in medicine [...] Full article
Show Figures

Figure 1

3 pages, 4954 KB  
Review
MINOCA and Spontaneous Dissection: Aiagnosis and Therapy
by Sarah Bär and Lorenz Räber
Cardiovasc. Med. 2021, 24(4), 140; https://doi.org/10.4414/cvm.2022.02173 (registering DOI) - 1 Jul 2022
Viewed by 82
Abstract
Myocardial infarction with nonobstructive coronary arteries (MINOCA): Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is defined as MI according to the fourth universal definition of MI [1] without coronary stenosis ≥50% on coronary angiography, and without a specific alternate diagnosis for [...] Read more.
Myocardial infarction with nonobstructive coronary arteries (MINOCA): Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is defined as MI according to the fourth universal definition of MI [1] without coronary stenosis ≥50% on coronary angiography, and without a specific alternate diagnosis for the acute presentation [2, 3] [...] Full article
Show Figures

Figure 1

5 pages, 2633 KB  
Case Report
Caseous Calcification of the Mitral Annulus Leading to Symptomatic Mitral Stenosis
by Nieto Nathalie, Carballo David and Giannakopoulos Georgios
Cardiovasc. Med. 2021, 24(4), w10088; https://doi.org/10.4414/cvm.2021.02174 - 1 Jul 2021
Abstract
Caseous calcification of the mitral annu-lus (CCMA) is a rare variant of mitral annular calcification, which can be difficult to diagnose and can be misdiag-nosed as a cardiac tumour or abscess. Multimodality imaging is important for the diagnosis of this entity and to [...] Read more.
Caseous calcification of the mitral annu-lus (CCMA) is a rare variant of mitral annular calcification, which can be difficult to diagnose and can be misdiag-nosed as a cardiac tumour or abscess. Multimodality imaging is important for the diagnosis of this entity and to avoid unnecessary surgical treatment. We present the case of a 77-year-old female patient with initially asymp-tomatic CCMA who later developed third degree atrioven-tricular heart block. Four years after the initial diagnosis, she was admitted to hospital for acute heart failure due to mitral stenosis. Multimodality imaging including transthoracic and transoesophageal echocardiography, and computed tomography showed an increase in the size of the caseous calcification with symptomatic mitral stenosis. Full article
Show Figures

Figure 1

5 pages, 1349 KB  
Communication
Swiss Cardiology in the European Showcase
by Ruth Amstein
Cardiovasc. Med. 2021, 24(4), w10073; https://doi.org/10.4414/cvm.2021.02249 - 1 Jul 2021
Abstract
Cardiology Update Davos, 24–26 October 2021: The Cardiology Update in Davos is one of the the major meetings in the field of cardiology in Europe, with a long tradition [...] Full article
Show Figures

Figure 1

9 pages, 662 KB  
Review
Supraventricular Tachycardia
by Philipp Krisai and Christian Sticherling
Cardiovasc. Med. 2021, 24(4), w02167; https://doi.org/10.4414/cvm.2021.02167 - 1 Jul 2021
Abstract
Introduction. Supraventricular tachycardias (SVTs) are common in the general population and usually symptomatic [...] Full article
Show Figures

Figure 1

4 pages, 4289 KB  
Case Report
Flecainide Induced ST Segment Changes Can Mimic Pathological ECG Changes in Patients Undergoing Exercise Testing: A Case Report
by Matthias Kruzik, Maria Padrutt, Julia Stehli, Corinna Brunckhorst, Christian Schmied and David Niederseer
Cardiovasc. Med. 2021, 24(4), 184; https://doi.org/10.4414/cvm.2021.02178 - 1 Jul 2021
Cited by 1 | Viewed by 139
Abstract
BACKGROUND: Flecainide, a class IC antiarrhythmic drug, is used frequently in patients with supraventricular arrhythmias, mostly atrial fibrillation, and less commonly for ventricular arrhythmias. With its strong affinity to sodium channels in the cardiac cells it affects phase 0 of the action potential [...] Read more.
BACKGROUND: Flecainide, a class IC antiarrhythmic drug, is used frequently in patients with supraventricular arrhythmias, mostly atrial fibrillation, and less commonly for ventricular arrhythmias. With its strong affinity to sodium channels in the cardiac cells it affects phase 0 of the action potential leading to conduction slowing, which is reflected in widening of the QRS, and it can also prolong the PR interval. These unspecific electrocardiogram (ECG) changes may mimic myocardial ischaemia in patients undergoing myocardial stress testing. The current case report reflects the diagnostic difficulties arising from this phenomenon. CASE SUMMARY: A 66-year-old patient who had been treated with flecainide for a decade for atrial fibrillation showed significant QRS widening and ST segment depression during exercise testing. The patient did not exhibit symptoms of myocardial ischaemia. A subsequent single photon emission computed tomography (SPECT) scan revealed a 10–15% cardiac ischaemic area. Invasive coronary angiography showed a chronic, complete obstruction of the left circumflex artery, which was percutaneously revascularised. DISCUSSION: This case demonstrates how pharmacological effects of flecainide and other class IC antiarrhythmic drugs may lead to suspicion of cardiac ischaemia due to QRS widening and unspecific ST-segment changes. In these patients, accurate ECG interpretation is important to avoid unnecessary invasive procedures such as coronary angiography. On the other hand, significant underlying coronary artery disease may nonetheless be present, warranting invasive diagnostic testing. Noninvasive cardiac imaging may facilitate the process of distinguishing real ischaemia from flecainide-induced ECG changes. Full article
Show Figures

Figure 1

3 pages, 3707 KB  
Case Report
Balloon-Protection of the Left Phrenic Nerve During Epicardial Catheter Ablation of Ventricular Tachycardia
by David Garay, Laurent Roten, Tobias Reichlin and Samuel H. Baldinger
Cardiovasc. Med. 2021, 24(4), 179; https://doi.org/10.4414/cvm.2021.02179 - 1 Jul 2021
Viewed by 66
Abstract
During epicardial radiofrequency ablation procedures for ventricular tachycardia the proximity to the left phrenic nerve may limit or even prohibit ablation of the arrhythmia, especially in the lateral segments of the left ventricle. We report a case of successful epicardial ventricular tachycardia ablation [...] Read more.
During epicardial radiofrequency ablation procedures for ventricular tachycardia the proximity to the left phrenic nerve may limit or even prohibit ablation of the arrhythmia, especially in the lateral segments of the left ventricle. We report a case of successful epicardial ventricular tachycardia ablation with balloon-protection of the phrenic nerve and discuss necessary equipment and techniques. Full article
Show Figures

Figure 1

5 pages, 2733 KB  
Review
Hypertension in Frail Patients
by Andreas W. Schoenenberger
Cardiovasc. Med. 2021, 24(4), 164; https://doi.org/10.4414/cvm.2021.02176 - 1 Jul 2021
Viewed by 44
Abstract
Introduction. During the past two decades, the term “frailty” has become a vogue expression, with an exponentially growing use in the medical literature [...] Full article
Show Figures

Figure 1

6 pages, 870 KB  
Review
Advanced Heart Failure: When and What to Consider for Left Ventricular Assist Device Implantation?
by Roger Hullin, Julien Regamey, Patrick Yerly, Stefania Aur, Tamila Abdurashidova, Valentina Rancati, Piergiorgio Tozzi and Matthias Kirsch
Cardiovasc. Med. 2021, 24(4), 123; https://doi.org/10.4414/cvm.2021.02169 - 1 Jul 2021
Viewed by 52
Abstract
Survival and quality of life improved signiffcantly with the dramatic changes of heart failure (HF) treatment in the last decades [1]. An unanticipated consequence of this favorable development is the emergence of a patient population increasingly refractory to standard HF treatment. This paradox [...] Read more.
Survival and quality of life improved signiffcantly with the dramatic changes of heart failure (HF) treatment in the last decades [1]. An unanticipated consequence of this favorable development is the emergence of a patient population increasingly refractory to standard HF treatment. This paradox relates to the fact that none of the currently available drugs or devices completely silences HF disease or protects from the occurrence of new episodes of myocardial damage, the development of cardiorenal syndrom or right heart failure. Full article
Show Figures

Figure 1

13 pages, 15154 KB  
Article
Composite Graft Replacement of the Aortic Root: Experience in a Tertiary Care Teaching Institution
by Meyer Judith, Schoenhoff Florian and Carrel Thierry
Cardiovasc. Med. 2021, 24(4), 1; https://doi.org/10.4414/cvm.2021.02172 (registering DOI) - 1 Jul 2021
Viewed by 87
Abstract
Composite graft replacement is an established surgical procedure that radically treats pathologies of the aortic root, especially when the aortic valve cannot be spared. We analysed the intraoperative details and the short-term outcome of a large consecutive series of patients operated on in [...] Read more.
Composite graft replacement is an established surgical procedure that radically treats pathologies of the aortic root, especially when the aortic valve cannot be spared. We analysed the intraoperative details and the short-term outcome of a large consecutive series of patients operated on in a teaching tertiary institution. Out of 877 patients who received a composite graft during a 13-year period, we excluded all those who were operated on as an emergency because of a type A acute aortic dissection, those who underwent this procedure as a redo surgery and those who presented with a destructive endocarditis of the aortic root. Finally 622 patients with a mean age of 59.5 ± 12.5 years (range 16–85) were analysed. Of these, 423 patients (68%) were male, and the mean body mass index was 27.8 ± 4.3 kg/m2 (18.4–37.3). Annulo-aortic dilatation with or without aortic valve dysfunction was the most frequent indication (n = 448), bicuspid valve with aortic root and/or ascending aortic dilatation was found in 107 patients and typical aortic root dilatation in the presence of Marfan/Loeys-Dietz syndrome was found in 33 patients. A large majority of patients presented with moderate or severe aortic regurgitation (n = 409, 65%), and aortic stenosis was present in 164 patients (26.5%). Early mortality occurred in nine patients (1.4%). Causes of death were: low output syndrome in three patients, severe cerebrovascular complications in four and respiratory or multiorgan failure in one patient each. Multivariate logistic regression analysis showed that severely reduced left ventricular function (left ventricular ejection fraction [LVEF] <0.35) (odds ratio [OR] 4.9, 95% confidence interval [CI] 1.7–12.2), aortic regurgitation grade IV (OR 6.35, 95% CI 1.8–17.8), new York Heart Association functional class III or IV (OR 2.94, 95% CI 1.5–7.4) and need for additional coronary artery bypass graft surgery (OR 4.25, 95% CI 1.6–11.3) were the independent risk factors for mortality as well as for early morbidity. Composite graft replacement is a standard procedure to treat different pathologies of the aortic root and is associated with a low perioperative risk. This justifies liberal indications in the case of a moderately dilated aortic root (4.5–5 cm) in younger patients (<60 years) and in those with a particular cardiovascular risk profile. Full article
Show Figures

Figure 1

3 pages, 5465 KB  
Letter
Albrecht von Haller Young Investigator Awards 2021
by Thomas Lüscher
Cardiovasc. Med. 2021, 24(4), 02216; https://doi.org/10.4414/cvm.2021.02216 (registering DOI) - 1 Jul 2021
Viewed by 45
Abstract
Albrecht von Haller (1708 – 1777; Abb. 1) war ein bedeutender, umfassend gebildeter Arzt, Anatom, Physiologe und Naturforscher [...] Full article
6 pages, 3309 KB  
Review
Dissection Coronaire Spontanée
by Lesko Tomas, Deriaz Denis and Girod Grégoire
Cardiovasc. Med. 2021, 24(4), 02171; https://doi.org/10.4414/cvm.2021.02171 - 1 Jul 2021
Viewed by 61
Abstract
Spontaneous coronary artery dissection. Spontaneous coronary artery dissection (SCAD) has emerged recently as an underestimated cause of acute coronary syndrome (ACS), myocardial infarction and sudden cardiac death [...] Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop